Clinical Trial Update: Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Efti in patients with hormone receptor-positive, HER2-negative breast cancer; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• Efti

Snippet

Sponsor: George Washington University | Conditions: Breast Cancer, HER 2 Negative Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING